The counter had a total traded volume of 10:05AM shares so far with a turnover of Rs 4.49 crore on BSE. The stock traded at a price-to-earnings multiple of 69.1 and a price-to-book ratio of 6.51.
A higher P/E ratio shows investors are willing to pay a higher price for per rupee earnings given by the stock because of better future growth expectations.
The price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Biocon Ltd. belongs to the Pharma – Indian industry.
Promotor/FII Holding
Promoters held 60.64 per cent stake in the company as of 30-Sep-2021, while overseas investors and domestic institutional investors ownership stood at 16.3 per cent and 6.88 per cent, respectively.
Key Financials
The company reported consolidated sales of Rs 1945.3 crore for the quarter ended 30-Sep-2021, up 7.61 per cent from the previous quarter’s Rs 1807.8 crore and up 10.51 per cent from the year-ago quarter’s Rs 1760.3 crore.
Its profit for the latest quarter stood at Rs 138.3 crore, down 18.31 per cent from the same quarter a year ago.
